Your browser doesn't support javascript.
loading
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
Mackey, J R; Pienkowski, T; Crown, J; Sadeghi, S; Martin, M; Chan, A; Saleh, M; Sehdev, S; Provencher, L; Semiglazov, V; Press, M F; Sauter, G; Lindsay, M; Houé, V; Buyse, M; Drevot, P; Hitier, S; Bensfia, S; Eiermann, W.
Affiliation
  • Mackey JR; Department of Oncology, Cross Cancer Institute, Edmonton, Canada. Electronic address: john.mackey@trioncology.org.
  • Pienkowski T; Department of Oncology, Postgraduate Medical Education Centre, Warsaw, Poland.
  • Crown J; All-Ireland Co-Operative Oncology Research Group, Dublin City University, Dublin, Ireland.
  • Sadeghi S; Department of Oncology, University of California, Los Angeles, USA.
  • Martin M; Department of Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.
  • Chan A; Breast Cancer Research Centre, WA & Curtin University, Perth, Australia.
  • Saleh M; Department of Oncology, University of Alabama Comprehensive Cancer Center, Birmingham, USA.
  • Sehdev S; Department of Oncology, William Osler Health Center, Brampton Civic Hospital, Brampton.
  • Provencher L; Department of Oncology, CHU de Québec/Université Laval, Québec, Canada.
  • Semiglazov V; Department of Oncology, Research Institute of Oncology N.N. Petrov Rosmedtechnologiy, St Petersburg, Russian Federation.
  • Press MF; Department of Pathology, University of Southern California, Los Angeles, USA.
  • Sauter G; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Lindsay M; Translational Research in Oncology, Edmonton, Canada.
  • Houé V; Translational Research in Oncology, Paris, France.
  • Buyse M; Biostatistics, International Drug Development Institute Statistics, Leuven, Belgium.
  • Drevot P; Translational Research in Oncology, Paris, France.
  • Hitier S; Clinical Studies, Sanofi, Paris, France.
  • Bensfia S; Clinical Studies, Sanofi, Paris, France.
  • Eiermann W; Gynecology and Obstetrics, Isarklinikum & IOZ, Munich, Germany.
Ann Oncol ; 27(6): 1041-1047, 2016 06.
Article in En | MEDLINE | ID: mdl-26940688
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Doxorubicin / Cyclophosphamide / Taxoids / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Doxorubicin / Cyclophosphamide / Taxoids / Drug-Related Side Effects and Adverse Reactions Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2016 Type: Article